Ex - vivo antimicrobial activity of Ayurvedic formulations - Kulkarni, Omkar;Wele, Asmita
35,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 1-2 Wochen
payback
18 °P sammeln
  • Broschiertes Buch

Development of newer dosage forms those can overcome the drawbacks of the traditional forms is the need of time. Choorna (fine powders) is the commonly practiced form for Ayurvedic formulations. Although this form is in routine practice for many years, Choorna has many drawbacks which can be tackled easily with development of Syrup and Suspension dosage forms. This is one of the first of its kind of study where along with standard in vitro antimicrobial evaluation the authors have used ex vivo studies using treated human serum. The book focuses on the development of newer dosage forms and validation of their antimicrobial potential.…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
Development of newer dosage forms those can overcome the drawbacks of the traditional forms is the need of time. Choorna (fine powders) is the commonly practiced form for Ayurvedic formulations. Although this form is in routine practice for many years, Choorna has many drawbacks which can be tackled easily with development of Syrup and Suspension dosage forms. This is one of the first of its kind of study where along with standard in vitro antimicrobial evaluation the authors have used ex vivo studies using treated human serum. The book focuses on the development of newer dosage forms and validation of their antimicrobial potential.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Omkar Kulkarni is MD with experience in research on formulations development for degenerative disorders. He has several publications and has been awarded from renowned organizations for academic excellence. Asmita Wele is MD and Professor in Ayurved with experience in Ayurvedic Pharmacology. She is recognized by different funding agencies.